Match!
Tetsuya Nakamura
Gunma University
5Publications
2H-index
37Citations
Publications 4
Newest
#1Sei-ichiro Motegi (Gunma University)H-Index: 15
#2Buddhini Perera (Gunma University)H-Index: 5
Last.Osamu Ishikawa (Gunma University)H-Index: 52
view all 7 authors...
Source
#1Sei-ichiro Motegi (Gunma University)H-Index: 15
#2Kazuya Yamada (Gunma University)H-Index: 8
Last.Osamu Ishikawa (Gunma University)H-Index: 52
view all 7 authors...
Source
#1Sei-ichiro MotegiH-Index: 15
#2Akihito UeharaH-Index: 5
Last.Osamu IshikawaH-Index: 52
view all 9 authors...
8 CitationsSource
#1Sei-ichiro Motegi (Gunma University)H-Index: 15
#2Kazuya Yamada (Gunma University)H-Index: 8
Last.Osamu Ishikawa (Gunma University)H-Index: 52
view all 7 authors...
Currently, there is no satisfactory treatment for Raynaud's phenomenon (RP) in systemic sclerosis (SSc). Recently, it has been reported that botulinum toxin A (BTX-A) injection was effective for the treatment of RP in SSc patients. The objective was to assess the efficacy and safety of BTX-A on RP in Japanese SSc patients. In the prospective, case series study, 10 Japanese SSc patients with RP received 10 U of BTX-A injections into the hand. The change in severity of RP, including the frequency ...
29 CitationsSource
1